Clinical significance of circulating tumor DNA in localized non-small cell lung cancer: a systematic review and meta-analysis
- 31 October 2022
- journal article
- research article
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 23 (5) , 1621-1631
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Adjuvant therapy following surgery in non-small cell lung cancer (NSCLC)Surgery Today, 2015
- Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgeryGut, 2015
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Receiver Operating Characteristic Curve in Diagnostic Test AssessmentJournal of Thoracic Oncology, 2010
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysisThe Lancet Infectious Diseases, 2007
- Systematic reviews of evaluations of diagnostic and screening testsBMJ, 2001
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986